(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Smith & Nephew, Nautilus, and HSBC.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Smith & Nephew (SNN) | 29.68 | 6.53% | 2023-02-21 07:26:49 |
| 2 | Nautilus (NLS) | 2.03 | 4.64% | 2023-02-21 07:16:57 |
| 3 | HSBC (HSBC) | 38.94 | 4.28% | 2023-02-21 07:24:28 |
| 4 | ImmunoGen (IMGN) | 4.31 | 3.11% | 2023-02-21 04:43:12 |
| 5 | Texas Pacific Land (TPL) | 1845.27 | 2.81% | 2023-02-21 04:20:36 |
| 6 | General Mills (GIS) | 78.63 | 2.42% | 2023-02-21 07:23:53 |
| 7 | Rio Tinto (RIO) | 76.13 | 2.27% | 2023-02-21 07:26:31 |
| 8 | Medtronic (MDT) | 86.65 | 2.18% | 2023-02-21 07:25:17 |
| 9 | POSCO (PKX) | 65.43 | 2.17% | 2023-02-21 07:26:05 |
| 10 | XP (XP) | 13.19 | 2.17% | 2023-02-21 07:05:13 |
The three biggest losers today are JD.com, Pinduoduo, and DocuSign.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | JD.com (JD) | 48.63 | -8.28% | 2023-02-21 07:28:24 |
| 2 | Pinduoduo (PDD) | 87.66 | -6.17% | 2023-02-21 07:33:54 |
| 3 | DocuSign (DOCU) | 60.60 | -6% | 2023-02-21 07:32:50 |
| 4 | Sorrento Therapeutics (SRNE) | 0.29 | -5.39% | 2023-02-21 07:30:48 |
| 5 | Credit Suisse Group (CS) | 2.86 | -5.3% | 2023-02-21 07:22:30 |
| 6 | Canopy Growth (CGC) | 2.38 | -5.18% | 2023-02-21 07:28:11 |
| 7 | 10x Genomics (TXG) | 49.07 | -4.92% | 2023-02-21 07:04:43 |
| 8 | Home Depot (HD) | 304.70 | -4.17% | 2023-02-21 07:31:37 |
| 9 | Walmart (WMT) | 141.21 | -3.57% | 2023-02-21 07:21:44 |
| 10 | Vanguard Total International Bond (BNDX) | 46.53 | -3.46% | 2023-02-21 04:24:56 |
Premarket Winners today
1. Smith & Nephew (SNN) – Premarket: 6.53%
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
NYSE ended the session with Smith & Nephew jumping 0.69% to $27.86 on Tuesday while NYSE fell 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $1.02.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 27.21. Meaning, the purchaser of the share is investing $27.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.25%.
Yearly Top and Bottom Value
Smith & Nephew’s stock is valued at $27.86 at 07:34 EST, way under its 52-week high of $36.14 and way above its 52-week low of $21.78.
Moving Average
Smith & Nephew’s worth is above its 50-day moving average of $27.82 and above its 200-day moving average of $26.88.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 28, 2022, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.63%.
Volatility
Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.58%, a negative 0.11%, and a positive 1.12%.
Smith & Nephew’s highest amplitude of average volatility was 0.87% (last week), 0.99% (last month), and 1.12% (last quarter).
More news about Smith & Nephew.
2. Nautilus (NLS) – Premarket: 4.64%
Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.
NYSE ended the session with Nautilus rising 3.74% to $1.94 on Tuesday, after five consecutive sessions in a row of gains. NYSE fell 0.21% to $15,840.16, after four sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Nautilus has a trailing twelve months EPS of $1.859.
PE Ratio
Nautilus has a trailing twelve months price to earnings ratio of 1.04. Meaning, the purchaser of the share is investing $1.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -75.41%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 52.6%, now sitting on 387.26M for the twelve trailing months.
Moving Average
Nautilus’s value is way higher than its 50-day moving average of $1.73 and above its 200-day moving average of $1.91.
Yearly Top and Bottom Value
Nautilus’s stock is valued at $1.94 at 07:34 EST, way under its 52-week high of $5.10 and way higher than its 52-week low of $1.23.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nautilus’s stock is considered to be oversold (<=20).
More news about Nautilus.
3. HSBC (HSBC) – Premarket: 4.28%
HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom.
NYSE ended the session with HSBC jumping 0.65% to $37.34 on Tuesday, after four successive sessions in a row of gains. NYSE fell 0.21% to $15,840.16, after four consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, HSBC has a trailing twelve months EPS of $1.47.
PE Ratio
HSBC has a trailing twelve months price to earnings ratio of 25.49. Meaning, the purchaser of the share is investing $25.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.03%.
Yearly Top and Bottom Value
HSBC’s stock is valued at $37.34 at 07:34 EST, under its 52-week high of $37.72 and way above its 52-week low of $24.77.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 17, 2022, the estimated forward annual dividend rate is 1.35 and the estimated forward annual dividend yield is 3.66%.
More news about HSBC.
4. ImmunoGen (IMGN) – Premarket: 3.11%
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen jumping 2.96% to $4.18 on Tuesday while NASDAQ slid 0.58% to $11,787.27.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.252.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -157.66%.
Moving Average
ImmunoGen’s worth is way below its 50-day moving average of $4.67 and way below its 200-day moving average of $4.92.
Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $4.18 at 07:34 EST, way below its 52-week high of $6.63 and way above its 52-week low of $3.10.
Volatility
ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.43%, a negative 0.61%, and a positive 2.77%.
ImmunoGen’s highest amplitude of average volatility was 3.41% (last week), 2.86% (last month), and 2.77% (last quarter).
More news about ImmunoGen.
5. Texas Pacific Land (TPL) – Premarket: 2.81%
Texas Pacific Land Corporation engages in the land and resource management, and water services and operations businesses. The company's Land and Resource Management segment manages approximately 880,000 acres of land. This segment also holds own a 1/128th nonparticipating perpetual oil and gas royalty interest (NPRI) under approximately 85,000 acres of land; a 1/16th NPRI under approximately 371,000 acres of land; and approximately 4,000 additional net royalty acres located in the western part of Texas. In addition, this segment engages in easements and commercial leases activities, such as oil, gas and related hydrocarbons, power line and utility easements, and subsurface wellbore easements. Further, this segment leases its land for processing, storage, and compression facilities and roads; and is involved in sale of materials, such as caliche. Its Water Services and Operations segment provides full-service water offerings, including water sourcing, produced-water gathering/treatment, infrastructure development, disposal solutions, water tracking, analytics, and well testing services to operators in the Permian Basin. This segment also holds royalties for water sourced from its land. Texas Pacific Land Corporation was founded in 1888 and is headquartered in Dallas, Texas.
NYSE ended the session with Texas Pacific Land dropping 4.26% to $1,794.75 on Tuesday, after five successive sessions in a row of losses. NYSE fell 0.21% to $15,840.16, after four successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Texas Pacific Land has a trailing twelve months EPS of $22.7.
PE Ratio
Texas Pacific Land has a trailing twelve months price to earnings ratio of 79.07. Meaning, the purchaser of the share is investing $79.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.39%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Texas Pacific Land’s stock is considered to be overbought (>=80).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 6, 2022, the estimated forward annual dividend rate is 12 and the estimated forward annual dividend yield is 0.64%.
More news about Texas Pacific Land.
6. General Mills (GIS) – Premarket: 2.42%
General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.
NYSE ended the session with General Mills jumping 2.21% to $76.77 on Tuesday while NYSE slid 0.21% to $15,840.16.
Earnings Per Share
As for profitability, General Mills has a trailing twelve months EPS of $4.12.
PE Ratio
General Mills has a trailing twelve months price to earnings ratio of 18.64. Meaning, the purchaser of the share is investing $18.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.16%.
Moving Average
General Mills’s worth is below its 50-day moving average of $81.27 and below its 200-day moving average of $76.99.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, General Mills’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
General Mills’s stock is valued at $76.77 at 07:34 EST, way under its 52-week high of $88.34 and way above its 52-week low of $61.67.
More news about General Mills.
7. Rio Tinto (RIO) – Premarket: 2.27%
Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company offers aluminum, copper, diamonds, gold, borates, titanium dioxide, salt, iron ore, and lithium. It also owns and operates open pit and underground mines, mills, refineries, smelters, power stations, and research and service facilities. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.
NYSE ended the session with Rio Tinto sliding 0.63% to $74.44 on Tuesday while NYSE dropped 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Rio Tinto has a trailing twelve months EPS of $6.
PE Ratio
Rio Tinto has a trailing twelve months price to earnings ratio of 12.41. Meaning, the purchaser of the share is investing $12.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.83%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10%, now sitting on 60.19B for the twelve trailing months.
More news about Rio Tinto.
8. Medtronic (MDT) – Premarket: 2.18%
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
NYSE ended the session with Medtronic rising 0.71% to $84.80 on Tuesday while NYSE dropped 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Medtronic has a trailing twelve months EPS of $2.26.
PE Ratio
Medtronic has a trailing twelve months price to earnings ratio of 37.54. Meaning, the purchaser of the share is investing $37.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.33%.
Yearly Top and Bottom Value
Medtronic’s stock is valued at $84.80 at 07:34 EST, way under its 52-week high of $114.31 and way above its 52-week low of $75.77.
More news about Medtronic.
9. POSCO (PKX) – Premarket: 2.17%
POSCO Holdings Inc., together with its subsidiaries, manufactures and sells steel rolled products and plates in South Korea and internationally. It operates through four segments: Steel, Construction, Trading, and Others. The company offers hot and cold rolled steel, steel plates, wire rods, galvanized sheets, electrical steel, stainless steel, and titanium. It also engages in the design, manufacture, and construction of steel mills and their facilities, and commercial and residential facilities; export and import of raw materials, as well as provision of supply and purchase transactions between domestic and foreign companies, and various steel products; power generation activities; and provision of network, system integration, and logistics services. In addition, the company is involved in the engineering and construction; research and consulting; architectural design and supervision; investment in venture, energy, and technology industries; electronic commerce; intellectual property services and consulting; transporting and warehousing; real estate development, rental, sale, and management; and education and real estate business. Further, it engages in the resource development; mine development; business facility maintenance; fuel cell; iron ore and coal sales; anode reproduction; and cargo handling business, as well as operates housing business agency. Additionally, the company is involved in the IT service and DVR; electric control engineering; forest resources development; refractory materials sales and furnace maintenance; quicklime manufacturing and sales; wastewater treatment operation and maintenance; rice processing; grain sales; and social enterprise businesses. POSCO Holdings Inc. was incorporated in 1968 and is headquartered in Pohang, South Korea.
NYSE ended the session with POSCO falling 0.33% to $64.04 on Tuesday, after two successive sessions in a row of losses. NYSE slid 0.21% to $15,840.16, after four successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, POSCO has a trailing twelve months EPS of $4.5.
PE Ratio
POSCO has a trailing twelve months price to earnings ratio of 14.24. Meaning, the purchaser of the share is investing $14.24 for every dollar of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 2.65 and the estimated forward annual dividend yield is 6.17%.
Volatility
POSCO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.13%, a negative 0.13%, and a positive 1.44%.
POSCO’s highest amplitude of average volatility was 1.27% (last week), 1.37% (last month), and 1.44% (last quarter).
Yearly Top and Bottom Value
POSCO’s stock is valued at $64.04 at 07:34 EST, above its 52-week high of $62.85.
More news about POSCO.
10. XP (XP) – Premarket: 2.17%
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
NASDAQ ended the session with XP falling 18.75% to $12.91 on Tuesday, after four successive sessions in a row of losses. NASDAQ dropped 0.58% to $11,787.27, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $0.99.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 13.09. Meaning, the purchaser of the share is investing $13.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.58%.
More news about XP.
Premarket Losers Today
1. JD.com (JD) – Premarket: -8.28%
JD.com, Inc. provides supply chain-based technologies and services in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, books, automobile accessories, apparel and footwear, bags, and jewelry. It also provides online marketplace services for third-party merchants; marketing services; and omni-channel solutions to customers and offline retailers, as well as online healthcare services. In addition, the company develops, owns, and manages its logistics facilities and other real estate properties to support third parties; and provides asset management services for logistics property investors. Further, it provides integrated data, technology, business, and user management industry solutions to support the digitization of enterprises and institutions. The company was formerly known as 360buy Jingdong Inc. and changed its name to JD.com, Inc. in January 2014. JD.com, Inc. was incorporated in 2006 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with JD.com falling 2% to $53.02 on Tuesday, following the last session’s downward trend. NASDAQ fell 0.58% to $11,787.27, after two consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, JD.com has a trailing twelve months EPS of $4.89.
PE Ratio
JD.com has a trailing twelve months price to earnings ratio of 10.84. Meaning, the purchaser of the share is investing $10.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.44%.
More news about JD.com.
2. Pinduoduo (PDD) – Premarket: -6.17%
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverages, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.
NASDAQ ended the session with Pinduoduo falling 3.48% to $93.42 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ fell 0.58% to $11,787.27, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Pinduoduo has a trailing twelve months EPS of $-0.93.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.76%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 65.1%, now sitting on 117.97B for the twelve trailing months.
Yearly Top and Bottom Value
Pinduoduo’s stock is valued at $93.42 at 07:34 EST, way below its 52-week high of $106.38 and way higher than its 52-week low of $23.21.
More news about Pinduoduo.
3. DocuSign (DOCU) – Premarket: -6%
DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management. The company provides Guided Forms, which enable complex forms to be filled via an interactive and step-by-step process; Click that supports no-signature-required agreements for standard terms and consents; Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Payments that enables customers to collect signatures and payment; Remote Online Notary is a solution using audio-visual and identify verification technologies to enable notarization; and Monitor using advanced analytics to track DocuSign eSignature web, mobile, and API account. It offers industry-specific cloud offerings, including Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; Rooms for Mortgage, which offers digital workspace to create and close mortgages; FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise, commercial, and small businesses. The company was incorporated in 2003 and is headquartered in San Francisco, California.
NASDAQ ended the session with DocuSign dropping 3.27% to $64.47 on Tuesday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, DocuSign has a trailing twelve months EPS of $-1.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.5%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.3%, now sitting on 2.44B for the twelve trailing months.
More news about DocuSign.
4. Sorrento Therapeutics (SRNE) – Premarket: -5.39%
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.
NASDAQ ended the session with Sorrento Therapeutics jumping 20.2% to $0.31 on Tuesday, after two successive sessions in a row of gains. NASDAQ fell 0.58% to $11,787.27, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -378.92%.
More news about Sorrento Therapeutics.
5. Credit Suisse Group (CS) – Premarket: -5.3%
Credit Suisse Group AG, together with its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company offers wealth management solutions, including investment advice and discretionary asset management services; risk management solutions, such as managed investment products; and wealth planning, succession planning, and trust services. It also provides financing and lending solutions, including consumer credit and real estate mortgage lending, real asset lending relating to ship, and aviation financing for UHNWI; standard and structured hedging, and lombard lending solutions, as well as collateral trading services; and investment banking solutions, such as global securities sales, trading and execution, capital raising, and advisory services. In addition, the company offers banking solutions, such as payments, accounts, debit and credit cards, and product bundles; asset management products; equity and debt underwriting, and advisory services; cash equities, equity derivatives, and convertibles, as well as prime services; and fixed income products, such as credit, securitized, macro, emerging markets, financing, structured credit, and other products. Further, it provides HOLT, a framework for assessing the performance of approximately 20,000 companies; and equity and fixed income research services. The company serves private and institutional clients; ultra-high-net-worth individuals, high-net-worth individuals, and affluent and retail clients; corporate clients, small and medium-sized enterprises, external asset managers, financial institutions, and commodity traders; and pension funds, hedge funds, governments, foundations and endowments, corporations, entrepreneurs, private individuals, financial sponsors, and sovereign clients. As of December 31, 2021, it operated through a network of 311 offices and branches. The company was founded in 1856 and is based in Zurich, Switzerland.
NYSE ended the session with Credit Suisse Group sliding 1.31% to $3.02 on Tuesday, after four sequential sessions in a row of losses. NYSE slid 0.21% to $15,840.16, after four consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Credit Suisse Group has a trailing twelve months EPS of $0.49.
PE Ratio
Credit Suisse Group has a trailing twelve months price to earnings ratio of 6.16. Meaning, the purchaser of the share is investing $6.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.09%.
Volatility
Credit Suisse Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.25%, a negative 0.80%, and a positive 2.97%.
Credit Suisse Group’s highest amplitude of average volatility was 1.55% (last week), 3.00% (last month), and 2.97% (last quarter).
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 8, 2022, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 2.86%.
Yearly Top and Bottom Value
Credit Suisse Group’s stock is valued at $3.02 at 07:34 EST, way under its 52-week high of $8.78 and higher than its 52-week low of $2.97.
More news about Credit Suisse Group.
6. Canopy Growth (CGC) – Premarket: -5.18%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth jumping 2.87% to $2.51 on Tuesday, after five sequential sessions in a row of gains. NASDAQ fell 0.58% to $11,787.27, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.239.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.
Volatility
Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.11%, a negative 0.92%, and a positive 4.60%.
Canopy Growth’s highest amplitude of average volatility was 6.44% (last week), 4.39% (last month), and 4.60% (last quarter).
Yearly Top and Bottom Value
Canopy Growth’s stock is valued at $2.51 at 07:34 EST, way under its 52-week high of $8.79 and way higher than its 52-week low of $2.09.
More news about Canopy Growth.
7. 10x Genomics (TXG) – Premarket: -4.92%
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
NASDAQ ended the session with 10x Genomics jumping 0.35% to $51.61 on Tuesday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, 10x Genomics has a trailing twelve months EPS of $-4.17.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.22%.
More news about 10x Genomics.
8. Home Depot (HD) – Premarket: -4.17%
The Home Depot, Inc. operates as a home improvement retailer. It operates The Home Depot stores that sell various building materials, home improvement products, lawn and garden products, and décor products, as well as facilities maintenance, repair, and operations products The company also offers installation services for flooring, cabinets and cabinet makeovers, countertops, furnaces and central air systems, and windows. In addition, it provides tool and equipment rental services. The company primarily serves homeowners; and professional renovators/remodelers, general contractors, maintenance professionals, handymen, property managers, building service contractors, and specialty tradesmen, such as electricians, plumbers, and painters. It also sells its products through websites, including homedepot.com; blinds.com, an online site for custom window coverings; and thecompanystore.com, an online site for textiles and décor products. As of December 31, 2021, the company operated 2,317 stores in the United States. The Home Depot, Inc. was incorporated in 1978 and is based in Atlanta, Georgia.
NYSE ended the session with Home Depot dropping 1.02% to $317.95 on Tuesday, following the last session’s downward trend. NYSE dropped 0.21% to $15,840.16, after four sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Could Home Depot inc. (hd stock) dip towards the 310 level?Today’s instrument is the Home Depot Inc.’s stock traded in NYSE exchange under the ticker HD.
: Home Depot stock sinks after sales miss and downbeat outlook, offsetting profit beat and dividend hikeShares of Home Depot Inc. dropped 2.8% toward a three-month low in premarket trading Tuesday, after the home improvement retail giant reported fiscal fourth-quarter sales that missed and provided a downbeat outlook, citing persistent inflation, continued supply chain disruptions and a tight labor market.
: Home Depot stock selloff cutting more than 70 points off the dow’s priceShares of Home Depot Inc. dropped 3.5% in premarket trading Tuesday, in the wake of the home improvement retailer’s slumped 262 points, or 0.8%.
Earnings Per Share
As for profitability, Home Depot has a trailing twelve months EPS of $11.94.
PE Ratio
Home Depot has a trailing twelve months price to earnings ratio of 26.63. Meaning, the purchaser of the share is investing $26.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1465.5%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Home Depot’s stock is considered to be overbought (>=80).
Volatility
Home Depot’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a positive 0.05%, and a positive 1.27%.
Home Depot’s highest amplitude of average volatility was 0.88% (last week), 1.26% (last month), and 1.27% (last quarter).
More news about Home Depot.
9. Walmart (WMT) – Premarket: -3.57%
Walmart Inc. engages in the operation of retail, wholesale, and other units worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores; membership-only warehouse clubs; ecommerce websites, such as walmart.com, walmart.com.mx, walmart.ca, flipkart.com, and samsclub.com; and mobile commerce applications. The company offers grocery and consumables, which includes dairy, meat, bakery, deli, produce, dry, chilled or frozen packaged foods, alcoholic and nonalcoholic beverages, floral, snack foods, candy, other grocery items, health and beauty aids, paper goods, laundry and home care, baby care, pet supplies, and other consumable items; and health and wellness products covering pharmacy, over-the-counter drugs and other medical products, and optical and hearing services. It also provides gasoline stations and tobacco; home improvement, outdoor living, gardening, furniture, apparel, jewelry, tools and power equipment, housewares, toys, seasonal items, mattresses, and tire and battery centers; and consumer electronics and accessories, software, video games, office supplies, appliances, and third-party gift cards. In addition, the company offers fuel and financial services and related products, including money orders, prepaid cards, money transfers, and check cashing and bill payment, as well as various types of installment lending. It operates through various e-commerce websites under 46 banners. The company was formerly known as Wal-Mart Stores, Inc. and changed its name to Walmart Inc. in February 2018. The company was founded in 1945 and is based in Bentonville, Arkansas.
NYSE ended the session with Walmart jumping 1.5% to $146.44 on Tuesday, after two sequential sessions in a row of gains. NYSE slid 0.21% to $15,840.16, after four successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
The Walmart (wmt stock) way One seasonal aspect to note for Walmart is that the stock tends to see a strong March.
Earnings Per Share
As for profitability, Walmart has a trailing twelve months EPS of $4.75.
PE Ratio
Walmart has a trailing twelve months price to earnings ratio of 30.83. Meaning, the purchaser of the share is investing $30.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.53%.
Volume
Today’s last reported volume for Walmart is 8256940 which is 45.33% above its average volume of 5681460.
Moving Average
Walmart’s worth is way above its 50-day moving average of $132.54 and above its 200-day moving average of $137.34.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Walmart’s stock is considered to be oversold (<=20).
Volatility
Walmart’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.77%, a negative 0.02%, and a positive 0.91%.
Walmart’s highest amplitude of average volatility was 1.08% (last week), 0.94% (last month), and 0.91% (last quarter).
Previous days news about Walmart
- Could Walmart (wmt stock) rise towards the 153 level?. According to FXStreet on Monday, 20 February, "Today’s instrument is the Walmart Inc.’s stock traded in NYSE exchange under the ticker WMT. "
More news about Walmart.
10. Vanguard Total International Bond (BNDX) – Premarket: -3.46%
NASDAQ ended the session with Vanguard Total International Bond rising 0.21% to $48.20 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.58% to $11,787.27, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Vanguard Total International Bond has a trailing twelve months EPS of $1.48.
Volatility
Vanguard Total International Bond’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a negative 0.05%, and a positive 0.33%.
Vanguard Total International Bond’s highest amplitude of average volatility was 0.20% (last week), 0.31% (last month), and 0.33% (last quarter).
More news about Vanguard Total International Bond.
Stay up to date with our premarket winners and losers daily report
